Mangoceuticals, Inc.
MGRX
$0.34
$0.012.29%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.49M | 481.30K | 101.00K | 76.50K | 58.70K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.10K | 100.00K | -- | 83.20K | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 54.00K | 16.90K | 16.90K | 16.90K | 16.90K |
| Total Current Assets | 1.55M | 598.20K | 118.00K | 176.70K | 75.60K |
|
|
|||||
| Total Current Assets | 1.55M | 598.20K | 118.00K | 176.70K | 75.60K |
| Net Property, Plant & Equipment | 309.70K | 13.30K | 30.00K | 166.10K | 182.10K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 14.23M | 15.92M | 20.69M | 21.53M | 15.23M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -119.80K | -119.80K |
| Total Assets | 16.09M | 16.53M | 20.84M | 21.75M | 15.37M |
|
|
|||||
| Total Accounts Payable | 416.70K | 527.00K | 768.00K | 1.18M | 837.50K |
| Total Accrued Expenses | 9.40K | 4.50K | 33.00K | -- | -- |
| Short-term Debt | -- | 100.00K | 600.00K | -- | 150.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 307.80K | 12.20K | 30.10K | 47.70K | 65.00K |
| Total Finance Division Other Current Liabilities | 156.60K | 160.70K | 169.90K | 277.30K | 373.00K |
| Total Other Current Liabilities | 156.60K | 160.70K | 169.90K | 277.30K | 373.00K |
| Total Current Liabilities | 890.60K | 804.30K | 1.60M | 1.50M | 1.43M |
|
|
|||||
| Total Current Liabilities | 890.60K | 804.30K | 1.60M | 1.50M | 1.43M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 100.00K | 600.00K | -- | 150.00K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 890.60K | 804.30K | 1.60M | 1.50M | 1.43M |
|
|
|||||
| Common Stock & APIC | 55.53M | 53.28M | 50.80M | 45.87M | 34.79M |
| Retained Earnings | -40.65M | -37.88M | -31.65M | -25.94M | -20.00M |
| Treasury Stock & Other | 321.50K | 322.20K | 97.70K | 322.10K | -835.60K |
| Total Common Equity | 15.20M | 15.73M | 19.24M | 20.25M | 13.95M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
|
|
|||||
| Total Common Equity | 15.20M | 15.73M | 19.24M | 20.25M | 13.95M |
| Total Preferred Equity | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Total Minority Interest | -1.50K | -1.70K | -1.20K | -1.20K | -1.10K |
| Total Equity | 15.20M | 15.73M | 19.24M | 20.25M | 13.95M |
|
|
|||||